Swisspartners Advisors LTD Abb Vie Inc. Transaction History

Swisspartners Advisors LTD

$126 Million
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 02, 2023	BUY	$133.59 - $154.65 $94,848 - $109,801	710 Added 0.86%	83,098 $12.4 Million
Q2 2023 Aug 07, 2023	SELL	$132.51 - $164.9 $22,526 - $28,033	-170 Reduced 0.21%	82,388 $11.1 Million
Q1 2023 May 09, 2023	SELL	$144.61 - $166.54 $572,655 - $659,498	-3,960 Reduced 4.58%	82,558 $13.2 Million
Q4 2022 Feb 07, 2023	SELL	$138.31 - $165.87 $287,961 - $345,341	-2,082 Reduced 2.35%	86,518 $14 Million
Q3 2022 Nov 01, 2022	SELL	$134.21 - $153.93 $1.91 Million - $2.19 Million	-14,204 Reduced 13.82%	88,600 $11.9 Million
Q2 2022 Aug 10, 2022	BUY	$137.62 - $174.96 $98,398 - $125,096	715 Added 0.7%	102,804 $16.3 Million
Q1 2022 May 04, 2022	BUY	$131.98 - $163.75 $66,649 - $82,693	505 Added 0.5%	102,089 $16.5 Million
Q4 2021 Feb 09, 2022	BUY	$107.43 - $135.93 $58,012 - $73,402	540 Added 0.53%	101,584 $13.9 Million
Q3 2021 Nov 17, 2021	BUY	$106.4 - $120.78 $2.1 Million - $2.39 Million	19,765 Added 24.32%	101,044 $10.9 Million
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $628,629 - $700,329	5,975 Added 7.93%	81,279 $9.16 Million
Q1 2021 May 12, 2021	SELL	$102.3 - $112.62 $2.65 Million - $2.92 Million	-25,905 Reduced 25.6%	75,304 $8.15 Million
Q4 2020 Feb 11, 2021	BUY	$80.49 - $108.67 $173,858 - $234,727	2,160 Added 2.18%	101,209 $10.7 Million
Q3 2020 Oct 19, 2020	SELL	$85.91 - $100.83 $262,540 - $308,136	-3,056 Reduced 2.99%	99,049 $8.68 Million
Q2 2020 Aug 04, 2020	SELL	$73.37 - $98.18 $64,565 - $86,398	-880 Reduced 0.85%	102,105 $10 Million
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $134,224 - $203,500	2,081 Added 2.06%	102,985 $7.85 Million
Q4 2019 Mar 09, 2020	BUY	$72.13 - $90.25 $7.28 Million - $9.11 Million	100,904 New	100,904 $8.93 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swisspartners Advisors LTD, based on Form 13F filings with the SEC.

News

Stay updated on Swisspartners Advisors LTD with notifications on news.

Account